| Date Filed | Type | Description |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.64, valued at
$92.4k
|
|
| 06/08/2023 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
| 09/02/2022 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 10,391 options to buy
@ $55.58, valued at
$577.5k
|
|
| 06/17/2022 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 26,000 options to buy
@ $4.8, valued at
$124.8k
|
|
| 05/13/2022 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 26,000 options to buy
@ $5.52, valued at
$143.5k
|
|
| 01/31/2022 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Granted 300,000 options to buy
@ $8.01, valued at
$2.4M
|
|
| 07/08/2021 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 614 shares
@ $115.38, valued at
$70.8k
Sold 200 shares
@ $116.41, valued at
$23.3k
Sold 200 shares
@ $118.35, valued at
$23.7k
Sold 100 shares
@ $119.68, valued at
$12k
Sold 200 shares
@ $120.39, valued at
$24.1k
Sold 400 shares
@ $121.59, valued at
$48.6k
Sold 100 shares
@ $122.85, valued at
$12.3k
Sold 200 shares
@ $123.76, valued at
$24.8k
Sold 300 shares
@ $124.31, valued at
$37.3k
Sold 100 shares
@ $126.51, valued at
$12.7k
Sold 100 shares
@ $128.67, valued at
$12.9k
|
|
| 06/30/2021 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 26,000 options to buy
@ $5.59, valued at
$145.3k
|
|
| 06/30/2021 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 5,787 shares
@ $105.37, valued at
$609.8k
Sold 3,196 shares
@ $106.28, valued at
$339.7k
Sold 1,162 shares
@ $107.22, valued at
$124.6k
Sold 900 shares
@ $108.3, valued at
$97.5k
Sold 1,000 shares
@ $109.39, valued at
$109.4k
Exercised 12,045 options to buy
@ $17, valued at
$204.8k
|
|
| 06/28/2021 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 25,000 options to buy
@ $4.18, valued at
$104.5k
|
|
| 06/14/2021 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 6,877 options to buy
@ $87.91, valued at
$604.6k
|
|
| 05/20/2021 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Granted 15,107 options to buy
@ $47.01, valued at
$710.2k
|
|
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 25,000 options to buy
@ $9.14, valued at
$228.5k
|
|
| 06/04/2020 |
3
| COOPER GRAHAM K (Director) has filed a Form 3 on Applied Molecular Transport Inc. |
| 02/11/2020 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 31,220 options to buy
@ $17, valued at
$530.7k
|
|
| 02/05/2020 |
3
| COOPER GRAHAM K (Director) has filed a Form 3 on Beam Therapeutics Inc. |
| 06/27/2019 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 8,896 options to buy
@ $7.63, valued at
$67.9k
|
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2019 |
4
| COOPER GRAHAM K (See Remarks) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 17,500 shares
@ $0
Granted 35,000 options to buy
@ $19.69, valued at
$689.2k
|
|
| 12/14/2018 |
4
| COOPER GRAHAM K (See Remarks) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 06/20/2018 |
3
| COOPER GRAHAM K (Director) has filed a Form 3 on Kezar Life Sciences, Inc. |
| 05/04/2018 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Granted 10,169 options to buy
@ $17, valued at
$172.9k
|
|
| 05/02/2018 |
3
| COOPER GRAHAM K (Director) has filed a Form 3 on Unity Biotechnology, Inc. |
| 03/12/2018 |
4
| COOPER GRAHAM K (See Remarks) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 220,000 options to buy
@ $57.53, valued at
$12.7M
|
|
| 03/12/2018 |
3
| COOPER GRAHAM K (See Remarks) has filed a Form 3 on ASSEMBLY BIOSCIENCES, INC. |
| 08/27/2015 |
4
| COOPER GRAHAM K (CFO) has filed a Form 4 on Receptos, Inc.|
Txns:
| Disposed/sold 10,500 shares
@ $0
Disposed/sold 96,665 options to buy
@ $5.1, valued at
$493k
Disposed/sold 50,000 options to buy
@ $18.77, valued at
$938.5k
Disposed/sold 36,945 options to buy
@ $41.51, valued at
$1.5M
|
|
| 06/05/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/03/2015 |
4
| COOPER GRAHAM K (CFO) has filed a Form 4 on Receptos, Inc.|
Txns:
| Granted 10,500 shares
@ $0 |
|
| 09/17/2014 |
4
| COOPER GRAHAM K (CFO) has filed a Form 4 on Receptos, Inc.|
Txns:
| Sold 50,000 shares
@ $61.3, valued at
$3.1M
Exercised 50,000 options to buy
@ $5.1, valued at
$255k
|
|
| 05/21/2014 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Celladon Corp|
Txns:
| Granted 10,000 options to buy
@ $9.58, valued at
$95.8k
|
|
|